Although Medicare and most health plans are reworking how they pay for health care, it will take years to eliminate the old way
A Harvard health economist and presidential campaign adviser says cost increases are on the right downward trajectory and will remain that way — as long as we keep pushing
With payers no longer the lone voice for real-world outcomes, who interprets value and how it is interpreted changes
Along with greater precision, they could bring opportunities to coordinate the efforts of health plans and PBMs
Minimally disruptive medicine, says the Mayo Clinic’s Victor Montori, is the kind of help today’s overwhelmed patients need
Biologics and high-cost medications are becoming mainstream, creating different challenges for insurers
A summary of ECRI Institute’s Emerging Technology Evidence Report
The FDA wants to significantly shorten the development time for new medications by cutting years out of the R&D process
In two studies, Lymphoseek outperformed previous agents in identifying nodes containing metastatic malignancies
The Affordable Care Act stunts the growth of these institutions, but will quality of care and competition suffer as a result?
News & Commentary
Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweißen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.